Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin
SEC filing record 1 source field available
Fiscal year end
31 December
Jazz Pharmaceuticals plc has filed 2,124 SEC EDGAR filings since 12 May 2003

SEC filing history

Showing 926-950 of 1,000 matching filings.

Per page
25
Current page
38
4

PRIMARY DOCUMENT

Filing date
09 Aug 2017
Reporting date
07 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33500

8-K

Filing date
08 Aug 2017
Reporting date
08 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Jul 2017
Reporting date
20 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Jul 2017
Reporting date
17 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33500

FORM 8-K

Filing date
03 Jul 2017
Reporting date
28 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Jun 2017
Reporting date
23 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33500

DEFA14A

Filing date
20 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33500

DEFA14A

Filing date
20 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33500

DEF 14A

Filing date
20 Jun 2017
Reporting date
03 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2017
Reporting date
15 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-33500

PRELIMINARY PROXY STATEMENT

Filing date
05 Jun 2017
Reporting date
03 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Jun 2017
Reporting date
01 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 May 2017
Reporting date
12 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 May 2017
Reporting date
11 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 May 2017
Reporting date
11 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 May 2017
Reporting date
11 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 May 2017
Reporting date
09 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33500

8-K

Filing date
09 May 2017
Reporting date
09 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 May 2017
Reporting date
05 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 May 2017
Reporting date
03 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Apr 2017
Reporting date
27 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Apr 2017
Reporting date
27 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-141164

CT ORDER filing

Filing date
27 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .